• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肝素-组织型纤溶酶原激活物复合物及其某些特性]

[The heparin--tissue plasminogen activator complex and some of its properties].

作者信息

Shimonaeva E E, Shimonaev G S, Aleshina T S

出版信息

Biokhimiia. 1983 Oct;48(10):1687-90.

PMID:6685533
Abstract

The complex formation between heparin and tissue plasminogen activator from pig heart "in vitro" was studied. It was shown that in solution heparin and tissue plasminogen activator form a complex with a molar ratio of 1:1. Evidence for the complex formation can be obtained by a shift in the isoelectric point for the activator in the presence of heparin and from IR spectral data. The fibrinolytic and anticoagulating properties of the heparin-tissue plasminogen activator complex were studied.

摘要

研究了肝素与猪心组织纤溶酶原激活剂在“体外”的复合物形成。结果表明,在溶液中肝素与组织纤溶酶原激活剂形成摩尔比为1:1的复合物。在肝素存在下激活剂的等电点变化以及红外光谱数据可作为复合物形成的证据。研究了肝素-组织纤溶酶原激活剂复合物的纤溶和抗凝特性。

相似文献

1
[The heparin--tissue plasminogen activator complex and some of its properties].[肝素-组织型纤溶酶原激活物复合物及其某些特性]
Biokhimiia. 1983 Oct;48(10):1687-90.
2
Plasminogen activator content in heart tissue and perfusate under various experimental conditions.不同实验条件下心脏组织和灌注液中的纤溶酶原激活剂含量。
Cor Vasa. 1983;25(3):206-12.
3
[Thrombolytic properties of the heparin-tissue plasminogen activator complex and its effect on the fibrinolytic and coagulating systems of the blood in animals].
Vopr Med Khim. 1988 Jan-Feb;34(1):59-62.
4
Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.纤溶酶原激活物抑制剂1含有一个隐蔽的高亲和力受体结合位点,该位点在与组织型纤溶酶原激活物形成复合物时暴露出来。
Thromb Haemost. 1998 Nov;80(5):822-8.
5
[A histochemical study of the distribution of plasminogen activator in myocardial tissue in experimental ischemia].[实验性缺血心肌组织中纤溶酶原激活物分布的组织化学研究]
Biull Eksp Biol Med. 1976 Feb;81(2):A61-3.
6
Changes in plasminogen activator activity and plasmin inhibition in the pig during experimental hypovolaemia.实验性低血容量期间猪体内纤溶酶原激活物活性和纤溶酶抑制作用的变化
Thromb Haemost. 1985 Feb 18;53(1):130-3.
7
Characterisation of the vascular plasminogen activator from the pig ear.
Folia Haematol Int Mag Klin Morphol Blutforsch. 1984;111(6):851-61.
8
Changes in pericardial morphology and fibrinolytic activity during cardiopulmonary bypass.体外循环期间心包形态和纤溶活性的变化。
J Thorac Cardiovasc Surg. 1993 Aug;106(2):339-45.
9
Both lysine-clusters of the NH2-terminal prion-protein fragment PrP23-110 are essential for t-PA mediated plasminogen activation.
Thromb Haemost. 2004 Mar;91(3):465-72. doi: 10.1160/TH03-06-0382.
10
Effect of heparin on the fibrinolytic response to plasminogen activators.肝素对纤溶酶原激活剂纤溶反应的影响。
Semin Thromb Hemost. 1991 Oct;17(4):389-93. doi: 10.1055/s-2007-1002641.

引用本文的文献

1
Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column.通过在组织型纤溶酶原激活剂-琼脂糖柱上进行色谱法对肝素进行分级分离。
Proc Natl Acad Sci U S A. 1990 Mar;87(5):1865-9. doi: 10.1073/pnas.87.5.1865.